Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Jun Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1088-1548; OpenAlex author ID A5041235189. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 3 papers · 2025: none · 2026: 2 papers

Papers 16

  1. Circ_0041150 inhibits proliferation of pancreatic adenocarcinoma cells by regulating triglyceride accumulation via the miR-1178-3p/AADAC axis. Last author DOI 10.1007/s12672-026-04577-1↗
  2. SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. Co-author DOI 10.1016/j.gendis.2025.101870↗
  3. Circ_0002395 promotes aerobic glycolysis and proliferation in pancreatic adenocarcinoma cells via miR-548c-3p/PDK1 axis. Last author DOI 10.1007/s10863-023-09995-2↗
  4. Circ_0124346 facilitates cell proliferation of pancreatic adenocarcinoma cells by regulating lipid metabolism via miR-223-3p/ACSL3 axis. Last author DOI 10.1007/s12672-024-01550-8↗
  5. Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma… Co-author DOI 10.1038/s41392-024-01948-4↗
  6. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Co-author DOI 10.1016/j.lfs.2019.116871↗
  7. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. First author DOI 10.3727/096504017x14934840662335↗
  8. Mitogen-activated protein kinase inhibition enhances the antitumor effects of sporamin in human pancreatic cancer cells. Last author DOI 10.3892/ol.2018.8746↗
  9. Sporamin induces apoptosis and inhibits NF-κB activation in human pancreatic cancer cells. Last author DOI 10.1177/1010428317706917↗
  10. Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer. Co-author DOI 10.3748/wjg.v23.i21.3907↗
  11. Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells. Last author DOI 10.3892/ol.2016.5097↗
  12. The advances of Midkine with peripheral invasion in pancreatic cancer. Co-author PMID 26609495↗
  13. Midkine promotes perineural invasion in human pancreatic cancer. Co-author DOI 10.3748/wjg.v20.i11.3018↗
  14. Recombinant lentivirus targeting the pleotrophin gene reduces pleotrophin protein expression in pancreatic cancer cells and inhibits neurite outgrowth of dorsa… Co-author DOI 10.3892/mmr.2014.1918↗
  15. Pleiotrophin promotes perineural invasion in pancreatic cancer. Co-author DOI 10.3748/wjg.v19.i39.6555↗
  16. PAd-shRNA-PTN reduces pleiotrophin of pancreatic cancer cells and inhibits neurite outgrowth of DRG. Co-author DOI 10.3748/wjg.v17.i21.2667↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cuijuan Qian · 6 shared papers, 2016–2026 · strength 1.12
  2. Meng-lu Shu · 2 shared papers, 2024 · strength 0.50
  3. Jing-jing Zhao · 1 shared paper, 2026 · strength 0.39
  4. Yijun Wei · 1 shared paper, 2026 · strength 0.29
  5. Haoran Li · 1 shared paper, 2026 · strength 0.29
  6. Yuchen Tang · 1 shared paper, 2026 · strength 0.29
  7. Bin Yi · 1 shared paper, 2026 · strength 0.29
  8. Jian Yang · 1 shared paper, 2026 · strength 0.29
  9. Jian Zhou · 1 shared paper, 2026 · strength 0.29
  10. Shegan Gao · 3 shared papers, 2014–2019 · strength 0.28
  11. Ce Zhang · 2 shared papers, 2018–2019 · strength 0.26
  12. Lulin Zhang · 2 shared papers, 2017–2018 · strength 0.21
  13. Chuntao Gao · 1 shared paper, 2024 · strength 0.15
  14. Jiuwei Cui · 1 shared paper, 2024 · strength 0.15
  15. Jufeng Wang · 1 shared paper, 2024 · strength 0.15
  16. Liwei Wang · 1 shared paper, 2024 · strength 0.15
  17. Zhihua Li · 1 shared paper, 2024 · strength 0.15
  18. Tao Xia · 1 shared paper, 2024 · strength 0.15
  19. Yuhong Zhou · 1 shared paper, 2024 · strength 0.15
  20. Jiujie Cui · 1 shared paper, 2024 · strength 0.15
  21. Deliang Fu · 1 shared paper, 2024 · strength 0.15
  22. Shukui Qin · 1 shared paper, 2024 · strength 0.15
  23. Shegan Gao · 1 shared paper, 2015 · strength 0.08
  24. Xin Zhang · 1 shared paper, 2016 · strength 0.07
  25. Xiaoshan Feng · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.